Glutamic Acid Decarboxylase Antibody (Gad Ab)

Glutamic Acid Decarboxylase (GAD) Antibody is an autoantibody that targets the enzyme glutamic acid decarboxylase, which is crucial for the synthesis of gamma- aminobutyric acid (GABA), a neurotransmitter that helps regulate brain activity. Elevated levels of GAD Abs are often associated with autoimmune conditions, such as type 1 diabetes and certain types of autoimmune neurological disorders, where the immune system mistakenly attacks and destroys the body’s own cell.

GAD antibody test is used to:

1. Diagnose autoimmune disorders particularly useful in diagnosing type 1 diabetes.
2. Assess autoimmune neurological disorders
3. Distinguish between diabetes types
4. Monitor disease progression – Individuals with known autoimmune conditions, the test can help monitor the activity and progression of the disease.

Testing for GAD antibodies is generally recommended for:

1. Individuals with suspected type 1 diabetes
2. Patients with Autoimmune neurological symptoms, like autoimmune epilepsy.
3. Patients with unexplained hyperglycaemia
4. For those who already diagnosed with autoimmune diseases where GAD Abs are relevant, testing can help attack disease progression or response to treatment.

GAD Antibodies are proteins produced by the immune system that mistakenly target and attack the enzyme glutamic acid decarboxylase, essential for regulating brain activity and insulin production. Elevated levels of GAD antibodies can indicate autoimmune conditions such as type 1 diabetes or certain neurological disorders. Testing for these antibodies helps in diagnosing these conditions and guiding appropriate treatment. GAD antibody levels can be crucial for effective management and intervention in autoimmune diseases.